Agrin: Difference between revisions
CSV import |
CSV import |
||
| Line 36: | Line 36: | ||
[[Category:Neuromuscular junction]] | [[Category:Neuromuscular junction]] | ||
{{No image}} | {{No image}} | ||
__NOINDEX__ | |||
Latest revision as of 03:34, 17 March 2025
Agrin[edit]
Agrin is a large proteoglycan that plays a crucial role in the development and maintenance of the neuromuscular junction (NMJ). It is a key component in the synaptic basal lamina and is essential for the clustering of acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells.
Structure[edit]
Agrin is a heparan sulfate proteoglycan, which means it consists of a core protein with covalently attached heparan sulfate chains. The protein is encoded by the AGRN gene in humans. Agrin is a large molecule, with multiple domains that allow it to interact with various components of the extracellular matrix and cell surface receptors.
Function[edit]
Agrin is primarily known for its role in the formation and maintenance of the neuromuscular junction. It is secreted by motor neurons and deposited in the synaptic basal lamina. Agrin binds to the muscle-specific kinase (MuSK) receptor on the surface of muscle cells, which initiates a signaling cascade that leads to the clustering of acetylcholine receptors at the synapse. This clustering is essential for effective synaptic transmission and muscle contraction.
Mechanism[edit]
The mechanism by which agrin induces AChR clustering involves several steps:
1. **Secretion and Binding**: Agrin is secreted by motor neurons and binds to the basal lamina at the neuromuscular junction. 2. **Activation of MuSK**: Agrin interacts with the MuSK receptor on the muscle cell membrane, activating it. 3. **Signal Transduction**: Activated MuSK initiates a signaling cascade involving several intracellular proteins, including rapsyn, which is crucial for AChR clustering. 4. **Receptor Clustering**: The signaling cascade results in the aggregation of acetylcholine receptors at the postsynaptic membrane, enhancing synaptic efficiency.
Clinical Significance[edit]
Mutations in the AGRN gene or disruptions in agrin signaling can lead to neuromuscular disorders. For example, congenital myasthenic syndromes (CMS) can result from defects in agrin or its signaling pathway, leading to muscle weakness and fatigue.
Research[edit]
Ongoing research is exploring the role of agrin in other tissues and its potential involvement in diseases beyond the neuromuscular junction, such as Alzheimer's disease and other neurodegenerative conditions.
Also see[edit]
| Neuroscience | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|